MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

Intuitive Surgical Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

508.85 1.09

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

503.3

Max

513.24

Pagrindiniai rodikliai

By Trading Economics

Pajamos

123M

688M

Pardavimai

374M

2.4B

P/E

Sektoriaus vid.

72.947

57.333

Pelnas, tenkantis vienai akcijai

2.21

Pelno marža

28.506

Darbuotojai

15,638

EBITDA

116M

810M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+16.53% upside

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-39B

168B

Ankstesnė atidarymo kaina

507.76

Ankstesnė uždarymo kaina

508.85

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Intuitive Surgical Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-04-22 20:55; UTC

Uždarbis

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

2025-01-23 21:41; UTC

Uždarbis

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

2025-01-21 18:37; UTC

Įsigijimai, susijungimai, perėmimai

Intuitive to Establish Direct Presence in Europe With Acquisition

2024-10-18 15:22; UTC

Uždarbis
Pagrindinės rinkos jėgos

Intuitive Surgical Shares Hit 52-Week High After 3Q Earnings, Revenue Beat Expectations

2024-10-17 21:33; UTC

Uždarbis
Pagrindinės rinkos jėgos

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

2024-10-17 20:56; UTC

Uždarbis

Intuitive Surgical Posts 3Q Revenue Growth

2025-04-22 20:13; UTC

Uždarbis

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

2025-04-22 20:05; UTC

Uždarbis

Intuitive Surgical 1Q EPS $1.92 >ISRG

2025-04-22 20:05; UTC

Uždarbis

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

2025-04-22 20:05; UTC

Uždarbis

Intuitive Surgical 1Q Net $698.4M >ISRG

2025-04-22 20:05; UTC

Uždarbis

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

2025-04-22 20:05; UTC

Uždarbis

Intuitive Surgical 1Q Rev $2.25B >ISRG

2025-01-24 21:17; UTC

Uždarbis

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

2025-01-24 18:18; UTC

Uždarbis

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

2025-01-24 13:11; UTC

Svarbiausios naujienos

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

2025-01-24 09:51; UTC

Karštos akcijos

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

2025-01-23 21:10; UTC

Uždarbis

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

2025-01-23 21:09; UTC

Uždarbis

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

2025-01-23 21:09; UTC

Uždarbis

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

2025-01-23 21:05; UTC

Uždarbis

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

2025-01-23 21:05; UTC

Uždarbis

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

2025-01-23 21:05; UTC

Uždarbis

Intuitive Surgical 4Q Rev $2.41B >ISRG

2025-01-23 21:05; UTC

Uždarbis

Intuitive Surgical 4Q Net $685.7M >ISRG

2025-01-23 21:05; UTC

Uždarbis

Intuitive Surgical 4Q EPS $1.88 >ISRG

2025-01-15 17:27; UTC

Uždarbis

Intuitive Surgical Stock Jumps. 'Da Vinci' Robots Guide the Future. -- Barrons.com

2025-01-06 12:00; UTC

Svarbiausios naujienos

Healthcare Stocks Are Down and Out. Opportunities Abound. -- Heard on the Street -- WSJ

2024-10-18 15:59; UTC

Uždarbis

Intuitive Surgical Breaks Out On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

2024-10-18 15:38; UTC

Uždarbis

Intuitive Surgical Stock Pops on Earnings Beat. What Wall Street Thinks of the Results. -- Barrons.com

2024-10-18 13:28; UTC

Uždarbis

Intuitive Surgical Eyes Breakout On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

2024-10-17 21:18; UTC

Uždarbis
Pagrindinės rinkos jėgos

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

Akcijų palyginimas

Kainos pokytis

Intuitive Surgical Inc Prognozė

Kainos tikslas

By TipRanks

16.53% į viršų

12 mėnesių prognozė

Vidutinis 592.13 USD  16.53%

Aukščiausias 675 USD

Žemiausias 470 USD

Remiantis 18 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Intuitive Surgical Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

18 ratings

15

Pirkti

3

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

489.52 / 517.31Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Weak Bullish Evidence

Ilgalaikis periodas

Bearish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.